|
Match
|
Document |
Document Title |
|
|
US20090285886 |
ENHANCED ANTIMICROBIAL ACTIVITY OF PLANT ESSENTIAL OILS
Antimicrobial compositions based on a combination of plant essential oils of enhanced antimicrobial effectiveness are prepared by adding to the combination of at least two plant essential oils, a...
|
|
|
US20090285885 |
Method of forming a drug nanocarrier having a magnetic shell
The invention discloses the synthesis and manufacturing of a novel core-shell nano-carrier with a drug-containing nanocomposite core surrounding with a single crystalline magnetic iron oxide shell....
|
|
|
US20090263475 |
DEXLANSOPRAZOLE COMPOSITIONS
Premixes of dexlansoprazole with pharmaceutical excipients, processes for preparing premixes, pharmaceutical formulations containing the premixes, and their use in treatment of erosive esophagitis...
|
|
|
US20090246274 |
PHARMACEUTICAL COMPOSITION 271
The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoi
midazole-5-carboxylic acid...
|
|
|
US20090232886 |
ORAL DOSAGE COMBINATION PHARMACEUTICAL PACKAGING
Pharmaceutical fixed dose combination products are formed by merging a fixed dose of a first pharmaceutical formulation from primary module, with a fixed dose of a second pharmaceutical formulation...
|
|
|
US20090232879 |
Thyromimetics for the Treatment of Fatty Liver Diseases
The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof, and to prodrugs of these compounds for...
|
|
|
US20090226511 |
NOVEL PHARMACEUTICAL FORMULATION IN THE FORM OF CELLULOSE CAPSULES SUITABLE FOR BENZIMIDAZOLE DERIVATIVES
A filled cellulose capsule for oral administration, wherein the capsule comprises a cellulose derivative as the base and the filling comprises a therapeutically effective amount of a benzimidazole...
|
|
|
US20090208567 |
SUBSTANCE-CONTAINING CARBON NANOHORN COMPOSITE HAVING POLYAMINE PLUG AND PROCESS FOR PRODUCING THE SAME
The present invention provides: a carbon nanohorn composite including a carbon nanohorn, a substance encapsulated in the carbon nanohorn, and a polyamine adsorbed by chemical reaction firmly to a...
|
|
|
US20090208566 |
Capsules Containing Seminal Material for Artificial Insemination
Capsules or microcapsules comprising: a) a nucleus containing seminal material or the spermatozoa of animal species chosen from the group consisting of equids, buffalo, ovicaprids, canids, felids,...
|
|
|
US20090202628 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced...
|
|
|
US20090191217 |
Anti-IL-1R1 Single Domain Antibodies And Therapeutic Uses
Disclosed is the use of an antagonist of Interleukin 1 receptor type 1 (IL-1R1) for the manufacture of a medicament treating, preventing or suppressing lung inflammation or a respiratory disease....
|
|
|
US20090186080 |
METHODOLOGY AND APPARATUS FOR ORAL DUAL DELIVERY OF HOMEOPATHIC PRODUCTS AND NON-HOMEOPATHIC PRODUCTS
One possible embodiment of the invention may be an oral dosage apparatus comprising of a sealed, digestible container having an exterior that defines and seals a respective interior; the interior...
|
|
|
US20090175934 |
Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
Disclosed herein is an extended release pharmaceutical formulation suitable for once daily administration, comprising a highly water soluble core consisting essentially of about 30 to about 40% by...
|
|
|
US20090169608 |
TOPICALLY APPLICABLE COMPOSITION FOR USE AS A SKIN BLEACHING AGENT
Topical composition for use especially as a skin lightener, characterized in that it contains an effective amount of at least one compound of general formula (I) or a mixture of such compounds...
|
|
|
US20090162428 |
Immediate disintegration polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof
An immediate disintegrating polymeric matrix for oral administration with modified release is disclosed, obtained without using inert supports such as sugar spheres, comprising particles of active...
|
|
|
US20090155353 |
MICROEMULSIONS FOR PHARMACEUTICAL COMPOSITIONS
The invention provides microemulsion pharmaceutical compositions comprising pharmaceutical actives which are hydrotropes that facilitate formation of microemulsions. The invention further provides...
|
|
|
US20090155352 |
Microemulsion containing indolocarbazole compound and dosage forms containing the same
The invention described herein provides a pharmaceutical composition and oral dosage forms containing the same, having high concentrations of solubilized indolocarbazole compounds as the active...
|
|
|
US20090155351 |
Solid Vaccine Formulation
The invention relates to a solid vaccine formulation adapted for mucosal administration comprising at least one antigen as active substance, wherein the formulation comprises a lyophilisate of a...
|
|
|
US20090148515 |
TWO-PIECE METAL CAPSULE FOR ACCOMMODATING PHARMACEUTICAL PREPARATIONS FOR POWDER INHALERS
The invention relates to novel two-piece metal capsules for accommodating pharmaceutical preparations to be used in powder inhalers as well as a method for producing said capsule. The inventive...
|
|
|
US20090148514 |
Multipart capsule for staged release of one or more pharmaceutical compositions
A multipart capsule, e.g., a dosage form, is provided which includes a plurality of capsule portions, at least one of which contains a substance to be released into a gastro-intestinal environment...
|
|
|
US20090148513 |
Compositions and methods for crystallizing antibodies
The present invention relates to a batch crystallization method for crystallizing anti-human TNFalpha (hTNFalpha) antibody and antibody fragments which allows the production of said antibody on an...
|
|
|
US20090148512 |
NOVEL USES OF CHLORAMPHENICOL AND ANALOGOUS THEREOF
A method for reducing the resistance of an MRSA bacterium to an antibiotic selected from the group consisting of vancomycin and methicillin comprising administering to a patient in need thereof an...
|
|
|
US20090142384 |
Viscoelastic material
The invention relates to a tough-elastic material based on starch, which on the one hand has high impact toughness at low humidities, and on the other hand still has a high modulus of elasticity at...
|
|
|
US20090130196 |
Bacteriophage composition
Bacteriophage compositions, and methods for preparing bacteriophage compositions are provided. The method for producing an antibacterial composition involves adsorbing an aqueous solution of one or...
|
|
|
US20090123386 |
Abuse Resistant Capsules
Hard shell capsules filled with a pharmaceutical medicament and at least one modifier, selected to prevent abuse of the medicament are described. The modifier may have a high melting point, and...
|
|
|
US20090117172 |
ORAL DELIVERY VEHICLE AND MATERIAL
Compositions for an oral delivery vehicle are described as well as methods for their manufacture and administration. The oral delivery vehicles can be made in any size or shape and can further...
|
|
|
US20090117163 |
Composition and Method for the Application of Human Synthetic Pheromones Using Substance Slowly Releasing Technological Bio Capsule in form of Drops in Clothing, Underwear, Jewels and Like
The invention regards a composition for the application of human synthetic pheromones in clothing, underwear, jewels, and like, comprising at least three positive human substances, e.g....
|
|
|
US20090110721 |
Paneled capsule shells for release of pharmaceutical compositions
Capsule shells for use in multi-part dosage forms have generally cylindrical shell members with a snap fit component on an interior surface adjacent an open end, for connection to a linker part of...
|
|
|
US20090098199 |
METHODS OF TREATING GASTROINTESTINAL DISORDERS INDEPENDENT OF THE INTAKE OF FOOD
The present invention relates to a method of treating a gastrointestinal disorder by administering to a patient in need of treatment thereof a pharmaceutical composition, wherein said...
|
|
|
US20090098198 |
Satiety
A capsule for suppressing appetite, comprising:
a) a shell which dissolves in the stomach; and b) a plurality of elements inside the shell, which elements expand inside the stomach, after...
|
|
|
US20090092658 |
NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS
The present invention relates to combinations of a proton pump inhibiting agent and at least one buffering agent that have been found to possess improved bioavailability, chemical stability,...
|
|
|
US20090087483 |
ORAL DOSAGE COMBINATION PHARMACEUTICAL PACKAGING
Pharmaceutical fixed dose combination products are formed by merging a fixed dose of a first pharmaceutical formulation from primary module, with a fixed dose of a second pharmaceutical formulation...
|
|
|
US20090081285 |
USE OF RADICAL-CAPTURING SUBSTANCES IN A TOPICAL PREPARATION FOR ANTIPYRETIC TREATMENT
The present invention relates to the use of one or more radical-capturing substances as therapeutically active substances in a topical preparation for antipyretic treatment. The invention is also...
|
|
|
US20090074856 |
CRYSTALLINE PYRIMIDINE NUCLEOSIDE DERIVATIVE SUSPENSIONS IN CAPSULES
The present invention relates to a pharmaceutical formulation which comprises (i) a capsule, and (ii) a core comprising crystalline 2′-cyano-2′-deoxy-N 4 -palmitoyl- 1...
|
|
|
US20090074854 |
COMBINED-STEP PROCESS FOR PHARMACEUTICAL COMPOSITIONS
The invention relates to a process for the solid oral pharmaceutical formulation of a pharmaceutically active ingredient such as levetiracetam, comprising a wet granulation of the pharmaceutically...
|
|
|
US20090068259 |
Controlled Surface Gelling of Mucoadhesive Polymers on Oral Mucosa
The present invention relates to an oral composition and method for alleviating the symptoms associated with xerostomia using encapsulated cation-releasing compounds formulated either intimately...
|
|
|
US20090053304 |
Composition and method of producing a taste masking formulation of laxatives for bowel cleaning preparation prior to colonoscopy
This invention relates to a solid taste masking formulation of laxatives which can be dispersed in water for oral use for bowel cleaning preparation prior to colonoscopy procedures. This invention...
|
|
|
US20090053303 |
MEDICAL FOOD OR NUTRITIONAL SUPPLEMENT, METHOD OF MANUFACTURING SAME, AND METHOD OF MANAGING DIABETES
A medical food and/or nutritional supplement for oral administration by mammals includes α-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the...
|
|
|
US20090035366 |
Nanoparticulate benzothiophene formulations
The present invention is directed to benzothiophene compositions, preferably nanoparticulate raloxifene hydrochloride compositions having improved pharmacokinetic profiles, improved...
|
|
|
US20090035365 |
Density Controlled Capsule Particles and Methods of Making the Same
The present invention discloses density controlled capsule particle and methods for making the same for use in a wide range of consumer and personal care products.
|
|
|
US20090028934 |
GRANULAR, GASTRO-RESISTANT PRODUCT BASED ON NIACIN OR DERIVATES THEREOF AND PROCESS FOR THE PRODUCTION OF SUCH A PRODUCT
A granular, gastro-resistant product based on niacin or derivatives thereof comprises an internal part in which the niacin is substantially concentrated and an external coating, provided to cover...
|
|
|
US20090028925 |
Novel Phosphinic Acid-Containing Thyromimetics
The present invention relates to compounds of phosphonic acid-containing T3 mimetics and monoesters thereof, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and...
|
|
|
US20090022786 |
Oral pharmaceutical dosage form and manufacturing method thereof
The present invention provides an coated oral pharmaceutical dosage form comprising a composition of a non-steroidal anti-inflammatory drug (NSAID) as multilayered spherical granule combined with a...
|
|
|
US20090022785 |
Permeable Capsules
The present invention relates to permeable capsules comprising at least one cell comprising a recombinant nucleic acid molecule with a heat inducible promoter operably linked to a nucleic acid...
|
|
|
US20090017110 |
MODIFIED RELEASE FORMULATIONS OF ANTI-IRRITABILITY DRUGS
Modified or extended release formulations containing mesalamine compounds and associated methods are disclosed and described. In some aspects, such formulations may be substantially bioequivalent...
|
|
|
US20090011007 |
Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water
The invention relates to a pharmaceutical composition comprising a mixture of at least one cationic, water-soluble (meth)acrylate copolymer, at least one water-insoluble polymer and at least one...
|
|
|
US20090011006 |
Once daily formulations of tetracyclines
Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent...
|
|
|
US20090010975 |
Non-transparent composition for film
The present invention provides a non-transparent film composition that has light-shielding properties and can thereby maintain the stability and quality of products, such as formulations, for a...
|
|
|
US20090004262 |
Nanoparticulate formulations and methods for the making and use therof
The present invention is directed to size-stabilized drug nanoparticulate compositions and methods of preparation thereof.
|
|
|
US20080317842 |
Fast Wet-Massing Method for the Preparation of Calcium-Containing Compositions
The present invention relates to a novel process for the preparation of a granulate comprising a calcium-containing compound as an active substance. The method comprises a method for the...
|